(Q33992247)

30 July 2017

title

Chimpanzee adenovirus vaccine protects against Zaire Ebola virus (English)

1 reference

30 July 2017

0 references

Orthoebolavirus zairense

0 references

1 reference

1 reference

0 references

James M Wilson

0 references

Heinz Feldmann

1 reference

30 July 2017

Gary P Kobinger

1 reference

30 July 2017

Friederike Feldmann

1 reference

30 July 2017

Yan Zhi

1 reference

30 July 2017

Gregory Schumer

series ordinal

1 reference

30 July 2017

Guangping Gao

series ordinal

1 reference

30 July 2017

Steven Jones

series ordinal

1 reference

30 July 2017

language of work or name

English

0 references

publication date

13 December 2005

1 reference

30 July 2017

1 reference

inferred from page(s)

published in

Virology

1 reference

30 July 2017

volume

346

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

394-401

1 reference

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Immune responses to adenovirus and adeno-associated virus in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Pathogenesis of experimental Ebola virus infection in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Replication-defective vector based on a chimpanzee adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Effects of a SARS-associated coronavirus vaccine in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Towards a vaccine against Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Vaccine research efforts for filoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.10.042

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2005.10.042

1 reference

30 July 2017

1 reference